FDA Import Refusal 112-1630386-9/1/1 — Catalent Pharma Solutions
The FDA refused shipment 112-1630386-9/1/1 from Catalent Pharma Solutions (United States) on May 30, 2006. The refused product falls under Drugs and Biologics — LAMIVUDINE (ANTI-VIRAL). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 30, 2006
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62VIY32 LAMIVUDINE (ANTI-VIRAL)
- Charges
- 75